What Mounjaro Maintenance Providers Should Actually Offer You

What the trial evidence tells us about the maintenance phase

The SURMOUNT-1 trial is worth understanding properly if you are approaching or already at a maintenance dose. Over 72 weeks, participants taking tirzepatide 15mg achieved average body-weight reductions of around 20–21%, results that only accumulated across the full treatment period. A withdrawal extension of the programme found that weight regain began relatively quickly once the medicine was stopped, an observation that has since shaped how prescribers think about long-term maintenance. The implication for patients is straightforward: this is not a short course that ends when a target weight is hit. It is an ongoing clinical commitment, and the NICE appraisal of tirzepatide (TA1026) reflects that, recommending clinical review at six months to assess whether the medicine is still producing meaningful benefit. Good maintenance providers build that review into their process; others skip it in favour of frictionless repeat orders.

Worth clearing up is a common misconception here: reaching a maintenance dose does not mean the hard clinical work is done. Some people assume that once they are stable on, say, 10mg or 15mg, repeat prescriptions are essentially administrative. They are not. A prescriber reviewing a maintenance prescription should still be asking whether your weight has continued to respond, whether side effects are well tolerated, whether any new health information has emerged, and whether the current dose remains the right one. That is a clinical judgement, not a checkbox.

What separates responsible Mounjaro providers at this stage

The difference between providers becomes most visible once patients are past the starter phase. At the consultation stage, most services look broadly similar. At maintenance, the gaps open up. A responsible provider will require current weight evidence before issuing each repeat prescription, not just your word, but a verifiable check. At nume, that means live weight verification on video as part of our standard process, which sits alongside photo-ID verification and GP notification in line with GPhC guidance. Our clinical team, led by GPhC-registered Independent Prescribers, personally reviews each repeat request, and if you want to understand what distinguishes the various Mounjaro providers currently operating in the UK, it is worth reading how their review processes compare before committing to one. You can read more about the clinical team behind those decisions on our clinical team profile page.

Providers worth trusting will also be transparent about what happens if you are not responding as expected. NICE guidance is explicit: if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed and may not be appropriate. A provider who never raises this (who simply keeps issuing the highest dose indefinitely) is not applying the clinical standard. Conversely, a provider who builds that review into every repeat cycle is doing exactly what the guidance intends. Our FAQs cover what our review process looks like in practice if you want the specifics.

Red flags in how some maintenance providers operate

Not every provider offering tirzepatide at maintenance dose operates to the same standard. Some of the patterns that should prompt caution are well documented. Providers who offer automatic repeat dispatches with no clinical re-review, or who process maintenance prescriptions without asking for any updated weight information, are making prescribing decisions on outdated data. That is a safety concern, not a minor administrative gap. The MHRA has been clear that GLP-1 medicines require proper clinical oversight throughout treatment, not just at initiation.

There is also the question of supply chain. Maintenance doses (particularly the higher strengths) have faced intermittent availability challenges in the UK market, so if you are ready to buy the Mounjaro maintenance dose at 15mg, it is worth confirming that your provider can reliably source it before you commit. A provider who cannot give you a clear answer about where your medicine comes from or who holds the GPhC registration for their pharmacy is not one you should trust with a long-term prescription. You can verify any online pharmacy directly on the GPhC register; nume's own GPhC premises registration number is 9012878 and is verifiable there. Our page on shady Mounjaro providers goes into more detail on the warning signs worth knowing. For broader context on accessing tirzepatide through private routes, the guide to buying Mounjaro online covers the legitimate steps involved.

What a sensible long-term maintenance arrangement looks like

At maintenance, the clinical relationship should feel like continuity, regular, proportionate, and honest. You should know who is prescribing for you, have a way to raise concerns between orders, and receive a clear explanation if anything about your prescription needs to change. The NHS maintenance dose pathway sets a useful reference point for what structured oversight looks like, even if you are accessing treatment privately. One question that comes up more often than you might expect is whether you can fulfil a Mounjaro prescription abroad, particularly among patients who travel frequently during a long-term course, and the answer has practical implications worth understanding before you find yourself in that situation.

Pricing at this stage is worth understanding too. Maintenance doses sit at the higher end of the Mounjaro strength range, and costs reflect that. Our treatment page shows current pricing transparently, with everything included: consultation, prescription, next-working-day tracked delivery, and 7-day aftercare support. There are no subscriptions, no auto-renewals, and no hidden fees, every repeat is reviewed afresh. For a prescription medicine, the right question at maintenance is never which provider is cheapest; it is which provider will still be applying proper clinical judgement six months from now. If you would like to talk through your situation with a prescriber, you are welcome to speak to our prescribers through a free consultation.